Gordon et al. Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial. Ann Oncol 2013. (4)
Publication
, Journal Article
Willett, CG; Chang, D; Czito, B; Meyer, J; Wo, J
Published in: International Journal of Radiation Oncology Biology Physics
December 1, 2013
Duke Scholars
Published In
International Journal of Radiation Oncology Biology Physics
DOI
EISSN
1879-355X
ISSN
0360-3016
Publication Date
December 1, 2013
Volume
87
Issue
5
Start / End Page
861 / 862
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Willett, C. G., Chang, D., Czito, B., Meyer, J., & Wo, J. (2013). Gordon et al. Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial. Ann Oncol 2013. (4). International Journal of Radiation Oncology Biology Physics, 87(5), 861–862. https://doi.org/10.1016/j.ijrobp.2013.09.006
Willett, C. G., D. Chang, B. Czito, J. Meyer, and J. Wo. “Gordon et al. Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial. Ann Oncol 2013. (4).” International Journal of Radiation Oncology Biology Physics 87, no. 5 (December 1, 2013): 861–62. https://doi.org/10.1016/j.ijrobp.2013.09.006.
Willett CG, Chang D, Czito B, Meyer J, Wo J. Gordon et al. Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial. Ann Oncol 2013. (4). International Journal of Radiation Oncology Biology Physics. 2013 Dec 1;87(5):861–2.
Willett, C. G., et al. “Gordon et al. Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial. Ann Oncol 2013. (4).” International Journal of Radiation Oncology Biology Physics, vol. 87, no. 5, Dec. 2013, pp. 861–62. Scopus, doi:10.1016/j.ijrobp.2013.09.006.
Willett CG, Chang D, Czito B, Meyer J, Wo J. Gordon et al. Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial. Ann Oncol 2013. (4). International Journal of Radiation Oncology Biology Physics. 2013 Dec 1;87(5):861–862.
Published In
International Journal of Radiation Oncology Biology Physics
DOI
EISSN
1879-355X
ISSN
0360-3016
Publication Date
December 1, 2013
Volume
87
Issue
5
Start / End Page
861 / 862
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences